- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs.
February 20, 2020
Current State of Systemic Therapies for Advanced Renal Cell Carcinoma.
February 19, 2020
Long non-coding RNA TCL6 enhances preferential toxicity of paclitaxel to renal cell carcinoma cells.
February 19, 2020
Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma.
February 19, 2020
Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma.
February 18, 2020
Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma.
February 17, 2020
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma.
February 14, 2020
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population.
February 14, 2020
Advancing serum peptidomic profiling by data-independent acquisition for clear-cell renal cell carcinoma detection and biomarker discovery.
February 14, 2020
Low Dosed Curcumin Combined with Visible Light Exposure Inhibits Renal Cell Carcinoma Metastatic Behavior In Vitro.
February 13, 2020
Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
February 13, 2020